France Fines Pharma Cos. €444M For Abuse Of Dominance
France's competition enforcer on Wednesday fined pharmaceutical companies Novartis and Roche a total of €444.9 million ($525.3 million) for allegedly abusing their collective dominance to preserve sales of a drug used...To view the full article, register now.
Already a subscriber? Click here to view full article